Evidence map›Paper›PMID 39421184›Full record

ArticleEcancermedicalscience2024

'Addressing HPV vaccine hesitancy: unveiling concerns and building trust' perspectives of adolescent girls and parents in Kisumu County, Kenya.

Edwin Onyango Ochomo, Philiph Tonui, Kapten Muthoka, Sayo Amboka, Peter Itsura, Elkanah Omenge Orang'o, Barry Rosen, Patrick Loehrer, Susan Cu-Uvin

Abstract read
In one paragraph

Article in Ecancermedicalscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Observational
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Edwin Onyango OchomoAMPATH, PO Box 4606 - 30100, Eldoret.
Philiph TonuiAMPATH, PO Box 4606 - 30100, Eldoret.
Kapten MuthokaAMPATH, PO Box 4606 - 30100, Eldoret.
Sayo AmbokaKEMRI - RCTP, PO Box 614 - 40100, Kisumu.
Peter ItsuraAMPATH, PO Box 4606 - 30100, Eldoret.
Elkanah Omenge Orang'oAMPATH, PO Box 4606 - 30100, Eldoret.
Barry RosenDivision of Gynecologic Oncology, Oakland University William Beaumont, Rochester Hills, MI, United States.
Patrick LoehrerIndiana University School of Medicine, Indianapolis, IN, USA.
Susan Cu-UvinBrown University, Providence, RI.

Funding

Brown/Moi Training Program for the Prevention of HIV related Cervical CancerD43TW011317 · FIC · BROWN UNIVERSITY · PI CU-UVIN, SUSAN · 2019 to 2023
$1.6M
FIC NIH HHS D43 TW011317
6 · The paper itself

Abstract

Introduction: Human papillomavirus (HPV) causes cervical cancer, and HPV vaccination is highly effective in preventing vaccine-targeted HPV infection. However, low HPV vaccination coverage in Kisumu County, Kenya, at about 10% for the first dose, highlights the critical issue of vaccine hesitancy, particularly in low and middle-income countries. Methods: This study explores the concerns, myths and barriers to HPV vaccine uptake among adolescent girls (aged 10-14) enrolled at human immune-deficiency virus comprehensive care clinics and their parents in Kisumu County. Focused group discussions were conducted with 48 participants. Results: Content analysis revealed limited knowledge about the HPV vaccine and widespread misconceptions regarding its safety and efficacy. Financial constraints, injection fears and negative clinic experiences emerged as additional barriers. Conclusion: The findings emphasise the role of effective communication strategies, including engaging parents through written materials and involving them in decision-making, to dispel myths, provide accurate information and encourage HPV vaccination. Collaborative efforts with community stakeholders are crucial to improve vaccine coverage and ultimately reduce the cervical cancer burden.

Indexed as

adolescent girlscervical cancerHPV vaccineKenyavaccine hesitancy

Identifiers

PMID39421184
PMCPMC11484676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.